How many insider declarations has Lucas Svetlana filed?

Lucas Svetlana has filed 3 public insider declarations with SEC (Form 4).

What is Lucas Svetlana's role?

Lucas Svetlana's reported role is not specified by the regulator across the filings.

Which companies does Lucas Svetlana report trades for?

Lucas Svetlana reports trades for 3 companies, including aTYR PHARMA INC.

What is Lucas Svetlana's declared buy vs sell volume?

Across the available history, declared buys total 81k€ and disposals 0.

← Executives ★ Sign in to follow

LS

Lucas Svetlana

·SEC (Form 4)

aTYR PHARMA INC Jasper Therapeutics, Inc.Scribe Therapeutics, Inc.

0

Total declarations

0

Companies

€80,585

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the full record of transactions filed by Lucas Svetlana. Director active across 3 companies, notably aTYR PHARMA INC. Cumulatively, 3 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €81k. Activity tracked since 22 September 2025. The latest transaction was disclosed on 23 July 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Lucas Svetlana

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

aTYR PHARMA INC (US)Jasper Therapeutics, Inc. (US)Scribe Therapeutics, Inc. (US)

Declarations3 total

▲

Lucas Svetlana

Chief Business OfficerExecutives23 Jul 2026Scribe Therapeutics, Inc.

$45,0000SEC ↗

3,000 shares@ US$15.00Common StockSEC:0001781292-26-000007:0

Canonical exit: 21 Oct 2026 (T+90)

▲

Lucas Svetlana

DirectorExecutives22 Sept 2025Jasper Therapeutics, Inc.

$48,60041SEC ↗

20,000 shares@ US$2.43100.0% of flowVoting Common StockSEC:0001213900-25-091104:0

Canonical exit: 21 Dec 2025 (T+90)

◇

Lucas Svetlana

DirectorExecutives26 Apr 2023aTYR PHARMA INC

11SEC ↗

6,000 sharesCommon stockSEC:0001209191-23-026065:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

LS

Lucas Svetlana

·SEC (Form 4)

aTYR PHARMA INC Jasper Therapeutics, Inc.Scribe Therapeutics, Inc.

0

Total declarations

0

Companies

€80,585

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the full record of transactions filed by Lucas Svetlana. Director active across 3 companies, notably aTYR PHARMA INC. Cumulatively, 3 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €81k. Activity tracked since 22 September 2025. The latest transaction was disclosed on 23 July 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.